XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 85,869 $ 69,767
Short-term investments 80,273 101,079
Accounts receivable, net 19,714 16,801
Inventory 21,998 21,772
Prepaid expenses and other current assets 15,445 25,477
Total current assets 223,299 234,896
Property and equipment, net 54,837 45,126
Goodwill 1,998 2,428
Other intangible asset 1,133 1,153
Long-term investments 492 1,961
Other assets 16,378 9,718
Total assets 298,137 295,282
Current liabilities:    
Accounts payable 13,889 11,052
Accrued expenses and other current liabilities 32,995 35,553
Financing liability — current 9,626 9,565
Midcap credit facility - current 11,667  
Deferred revenue — current 2,316 1,733
Recognized loss on purchase commitments — current 11,360 9,393
Total current liabilities 81,853 67,296
Mann Group convertible note 8,829 8,829
Accrued interest - Mann Group convertible note 54 55
Financing liability — long term 94,441 94,512
Midcap credit facility 27,704 39,264
Senior convertible notes 225,761 225,397
Recognized loss on purchase commitments — long term 59,829 62,916
Operating lease liability 4,879 5,343
Deferred revenue — long term 45,659 37,684
Milestone liabilities 4,524 4,524
Total liabilities 553,533 545,820
Commitments and contingencies (Note 15)
Stockholders' deficit:    
Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding as of March 31, 2023 and December 31, 2022
Common stock, $0.01 par value - 400,000,000 shares authorized, 264,278,760 and 263,793,305 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 2,643 2,638
Additional paid-in capital 2,969,225 2,964,293
Accumulated deficit (3,227,264) (3,217,469)
Total stockholders' deficit (255,396) (250,538)
Total liabilities and stockholders' deficit $ 298,137 $ 295,282